The histology of the parathyroids from 88 cases of primary hyperparathyroidism has been reviewed in a search for local amyloid deposits.
Local deposition of amyloid in tumours of endocrine glands is well documented in medullary carcinoma of the thyroid and islet cell tumours of the pancreas (Porta, Yerry, and Scott, 1962; Williams, Brown, and Doniach, 1966) . The finding of fairly large amounts of amyloid in a parathyroid removed for primary hyperparathyroidism and showing chief cell hyperplasia prompted a search for further cases.
Methods
Material from 88 patients was examined; 66 were from the London Hospital of whom 64 were cases of surgically treated primary hyperparathyroidism and two were necropsies to which our attention was drawn during the survey. The remaining 22 patients had parathyroids removed for primary hyperparathyroidism at King's College Hospital. Forty cases showed chief cell adenomas and 48 primary hyperplasia (Table I) .
Haematoxylin-and-eosin-stained sections were screened for deposits of amorphous eosinophilic Received for publication 15 April 1970. material resembling amyloid, and the development of anomalous colours when viewed between crossed polaroids (Brewer, 1964) was used as an additional check to eliminate the colloid often seen in parathyroids with a follicular pattern. Amyloid was then more definitely identified by Highman's Congo red and Thioflavine T stains. Methyl violet stains were used but were not consistent, being unhelpful in doubtful cases. Known primary and secondary amyloid sections were used as controls on all occasions. Examination of Congo red sections between crossed polaroids for dichroism (Ladewig, 1945) proved most useful; this method is regarded by most authorities as the best histological method for identifying amyloid (Cohen, 1967 (Table I ).
The main pathological findings in the parathyroids are summarized in Table II and the  clinical and other associated features in Table  III .
In the nine positive cases there is a wide age range (24-61 yr) and almost equal sex distribution (five female, four male). In seven cases the glands showed chief cell hyperplasia and in the remainder there were chief cell adenomas. The largest amyloid deposits were seen in the first parathyroid removed from case 1 (Table II) ; follicular areas showed extensive intrafollicular amyloid deposits (Fig. 1) . The cells surrounding the amyloid deposits were of moderate size with a round nucleus towards the base and the cytoplasm contained clear vacuoles. The staining reactions of these cells by PAS, Best's carmine, Bodian, and diazo methods did not differ from those of adjacent follicular and non-follicular parathyroid tissue not containing amyloid. In addition to these large and obvious areas of intrafollicular amyloid the adjacent hyperplastic parathyroid contained similar small foci of amyloid within tiny follicles scattered throughout the gland (Fig. 2) . It was these small deposits which were found in most of the other cases (Fig. 3) , although in some (case 6) larger areas were seen (Fig. 4) was often possible to examine more than one parathyroid from each case, and indeed cases 1, 5, and 7 had recurrent hyperparathyroidism necessitating further operations. It is apparent (Table II) that not all parathyroids from each case showed these deposits but this may merely represent a random distribution.
The deposits were not related to the site of the parathyroid. An impression was formed that they tend to occur near the periphery of the gland. Localized islands of these small amyloid-contamning acini were not seen.
In addition to the 88 cases of primary hyperparathyroidism 20 normal parathyroids from V :. routine postmortem cases were examined. Amyloid was not detected in any of these. Some corpora amylacea in prostate and lung were also examined. Those in the prostate took up Congo red but did not show birefringence. Some in the lung showed a regular laminated yellow-green birefringence but not the broken-up, apple-green dichroism as is seen in amyloid (Fig. 5) .
A M Y LO ID
The amyloid present showed dichroism in sections stained with Congo red and viewed in a polarizing microscope, and green fluorescence with thioflavine T stains in all cases (Fig. 5) . The tiny intrafollicular deposits often gave a Maltese cross pattern of birefringence (Fig. 3 ). Larger deposits sometimes had a concentric layered appearance (Figs. I and 5) . In case I the amyloid had broken out of some follicles into the stroma (Fig. 1) and macrophages with a few foreign body giant cells were closely applied to it within some large, possibly confluent, follicles (Fig. 6) . Amyloid was not seen involving other elements.
Electron microscopy of tissue from case 1 showed the non-branching fibrillar network composed of long, 75-IOOA-wide, fibres (Fig. 7) w\hich, together with the staining properties previously referred to, characterize amyloid. Electron microscope controls of known amyloid material, also previously paraffin-embedded, 
CLINICAL
When the clinical records of cases 1, 2, 4, and 5 were examined it was realized that they were members of two families having the pluriglandular syndrome, and that case 5 had been the subject of a previous report (Greenbaum, 1960) . This led to the examination of the postmortem records of case 3 (sister of case 1) and case 6, the subject of a pluriglandular syndrome previously reported (Marshall and Sloper, 1954 (Underdahl, Woolner, and Black, 1953; Wermer, 1963; Ballard, Frame, and Hartsock, 1964) . The reason for this lack of previous observation may reflect the fact that only tiny deposits are present in most glands. The significance of the observation is of greater interest.
It must be emphasized that these deposits do not relate to systemic amyloidosis either primary, familial, secondary, or senile. A careful study of postmortem material and records of the patients and families failed to reveal any such association. The cases presented show no predisposition to deposit amyloid anywhere other than in the parathyroid. The local amyloid must therefore be interpreted with reference to similar deposits in other endocrine-secreting tissue and to the normal or abnormal functions of the parathyroid glands.
The isolated amyloid fibril has been shown to be a protein (Cohen, 1966) , and therefore largely composed of peptides. Local deposits of amyloid are known to occur in islet cell tumours of the pancreas (Porta et al, 1962) , medullary carcinoma of the thyroid (Hazard, Hawk, and Crile, 1959; Williams et al, 1966) , and are now shown in the parathyroid. Peptide hormones are produced at all these sites and it is possible that the amyloid may represent polymerization of an aberrant peptide which may or may not be related to the particular hormone. However, amyloid deposits have not been recorded in pituitary tumours, carcinoid tumours, or oat-cell carcinoma of the bronchus associated with endocrine syndromes, all of which are known to produce peptide hormones. Thus the relationship may be more specifically with the three sites mentioned.
Amyloid deposits are a prominent feature of medullary carcinoma of the thyroid but their significance has not been elucidated and is not referred to in reviews of the subject (Hazard et al, 1959; Williams et al, 1966) . In these tumours the amyloid is stromal and not intrafollicular as in the parathyroids, where the appearances suggest a relationship to the secretions of surrounding cells. Small amyloid deposits completely surrounded by tumour cells are present in some medullary carcinomas . Tissue culture of medullary carcinoma shows rosette formation by the tumour cells with amyloid at the centre (Albores-Saavedra, Rose, Ibanez, Russell, Grey, and Dmochowski, 1964) , and amyloid fibrils have been seen in the cytoplasm of the tumour cells indicating production of amyloid by these cells (Gonzalez-Licea, Hartmann, and Yardley, 1968; Meyer, 1968) . The intrafollicular position of the amyloid in the parathyroids has the same connotation, and it should be noted that it is only in the larger follicles that macrophages can be seen and not in the tiny acini where amyloid is presumably just beginning to be deposited.
It has been shown that medullary carcinoma secretes calcitonin (Tashjian and Melvin, 1968; Cunliffe, Black, Hall, Johnston, Hudgson, Shuster, Gudmundsson, Joplin, Williams, Woodhouse, Galante, and Maclntyre, 1968; Tubiana, Milhaud, Coutis, Lacour, Parmentier, and Bok, 1968) , a peptide hormone with hypocalcaemic and hypophosphataemic action due to inhibition of bone resorption (Copp, Cameron, Cheney, Davidson, and Henze, 1962; Friedmann and Raisz, 1965) . Calcitonin-like activity has also been identified in normal human plasma (Gudmundsson, Byfield, Galente, Kenny, Maclntyre, Osafo, and Tse, 1968) , and it is probable that this hormone directly opposes parathormone in its bone resorptive action. Calcitonin is secreted by C-cells (Pearse, 1966) derived from the last branchial pouch, and medullary carcinoma of thyroid is almost certainly a tumour of these cells (Williams, 1966) . Amyloid deposition may be directly related to calcitonin secretion in medullary carcinoma, possibly representing aggregates of a closely related polypeptide produced by altered cellular metabolism, or even a normal calcitonin precursor produced in excess. Thus it may act as a marker of calcitonin secretion, and it is suggested that the same may apply in the parathyroid. Hypercalcaemia and calcitonin secretion are not incompatible as calcitonin only opposes parathormone in its actions on bone and not its effects in increasing calcium absorption from the intestinal tract (Spencer, Lewin, and Samachson, 1968) .
In support of the 'marker' hypothesis it should be noted that calcitonin activity has been shown in the human parathyroid, thyroid, and thymus (Galante, Gudmundsson, Matthews, Tse, Williams, Woodhouse, and Maclntyre, 1968) .
Thus it would appear that C-cells can be incorporated embryologically into all three glands. It would also be more likely that a hyperplastic or adenomatous gland would produce peptides closely related to its normal metabolism, whereas a variety of unrelated peptides might be produced by a neoplastic cell.
Against this view it might be argued first that intrafollicular amyloid should be seen in hyperparathyroidism much more frequently than indicated by the present study since the stimulus for calcitonin release is hypercalcaemia (Copp et al, 1962; Kumar, Foster, and Maclntyre, 1963) . However, it is not known whether the normal distribution of C-cells is uniform between parathyroid, thyroid, and thymus, and it is possible that there is considerable individual variation: a search for tiny deposits of amyloid within the thyroid or thymus of hypercalcaemic patients might be rewarding. Secondly there is our inability in this material either to identify the follicular cells as C-cells or to differentiate them from the surrounding parathyroid cells not associated with amyloid. C-cells are argyrophil (Nonidez, 1932) but, since argyrophilia is also one of the characteristics of normal parathyroid cells (Roth, 1962) , it is not a distinguishing characteristic. More detailed identification of these follicular cells must await the availability of material suitable for electron microscopy allowing a search for the secretory granules as seen in C-cells (Meyer and Abdel-Bari, 1968) and for immunofluorescent studies to locate the site of calcitonin production in the parathyroid.
If amyloid deposition does relate to calcitonin in medullary carcinoma and hyperparathyroidism it is difficult to associate this with the amyloid seen in islet cell tumours. Islet cells are derived from the foregut and have much in common with the other endocrine derivatives of this region. It is known that islet cell tumours may produce several peptide hormones but calcitonin has not been identified. However, glucagon, also a low molecular weight peptide hormone, has been shown to have a hypocalcaemic action in the rat (Williams, Bowser, and Henderson, 1969) .
The association of the intrafollicular amyloid deposits with the pluriglandular adenomatosis syndrome in seven of the cases may merely reflect the long duration of disturbed calcium metabolism. It is well known that hypercalcaemia is often asymptomatic in these families.
Thus it would appear that there are two possible explanations for the presence of intrafollicular amyloid in parathyroids in primary hyperparathyroidism: (1) a non-specific relationship with cells capable of peptide synthesis, or (2) a more specific association with a peptide related to calcitonin. The latter seems more likely at present but will remain speculative until more information is available concerning calcitonin levels in cases ofprimary and secondary hyperparathyroidism, and the site of calcitonin production in the parathyroids is identified by histochemical, immunofluorescent, and electron microscope methods.
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